Procter & Gamble Health Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Dec ' 23	Dec ' 22	Dec ' 21	Dec ' 20	Jun ' 19

Sales

614.90

607.52

550.70

504.19

464.66

Operating profit

190.31

201.20

139.91

166.85

104.66

Interest

0.37

0.39

0.26

0.43

-

Gross profit

201.17

208.77

147.39

178.86

139.82

EPS (Rs)

82.92

84.61

60.37

76.59

51.08

Other income

11.23

7.96

7.74

12.44

35.16

Stock adjustment

9.56

-26.28

-23.50

9.40

-29.20

Raw material

158.15

181.30

184.62

139.72

161.16

Power and fuel

-

-

-

-

-

Employee expenses

118.07

90.04

80.51

72.18

63.70

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

138.81

161.26

169.16

116.04

164.35

Provisions made

-

-

-

-

-

Depreciation

13.40

17.23

13.49

15.21

8.83

Taxation

50.13

51.08

33.69

36.51

46.20

Net profit / loss

137.64

140.46

100.21

127.14

84.79

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

16.60

16.60

16.60

16.60

16.60

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

30.95

33.12

25.41

33.09

22.52

GPM (%)

32.13

33.92

26.39

34.62

27.97

NPM (%)

21.98

22.82

17.94

24.61

16.96